Human umbilical cord mesenchymal stem cell-derived extracellular vesicles

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funder: Natural Science Foundation of Henan Province

Animals1

Outcomes

Inflammation

downin mice1

1 study

Human umbilical cord mesenchymal stem cell-derived extracellular vesicles decrease inflammation in mice.
“UCMSC-EVs markedly improved ovarian function, cellular apoptosis and inflammation of aging mice.”
Animalsovary
Mesenchymal stem cells derived extracellular vesicles ameliorate ovarian aging through inhibiting LGALS3BP/NF-κB induced inflammation
Journal of ovarian research22 Dec 2025

Latest

1 in 12 months

Journal of Ovarian Research23 Dec

Mesenchymal stem cells derived extracellular vesicles ameliorate ovarian aging through inhibiting LGALS3BP/NF-κB induced inflammation

Experiments in miceReproductive system

Paper

Human umbilical cord mesenchymal stem cell-derived extracellular vesicles

Outcomes

Latest

Mesenchymal stem cells derived extracellular vesicles ameliorate ovarian aging through inhibiting LGALS3BP/NF-κB induced inflammation

Related